These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 26615460)

  • 1. Characterization of NDM-1- and OXA-23-producing Acinetobacter baumannii isolates from inanimate surfaces in a hospital environment in Algeria.
    Zenati K; Touati A; Bakour S; Sahli F; Rolain JM
    J Hosp Infect; 2016 Jan; 92(1):19-26. PubMed ID: 26615460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First report of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and rapid spread of metallo-β-lactamase NDM-1 in Algerian hospitals.
    Bakour S; Touati A; Bachiri T; Sahli F; Tiouit D; Naim M; Azouaou M; Rolain JM
    J Infect Chemother; 2014 Nov; 20(11):696-701. PubMed ID: 25240726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of OXA-23 and OXA-58 Carbapenemases Coexpressed in Clinical Isolates of Acinetobacter baumannii in Tunisia.
    Mathlouthi N; Ben Lamine Y; Somai R; Bouhalila-Besbes S; Bakour S; Rolain JM; Chouchani C
    Microb Drug Resist; 2018 Mar; 24(2):136-141. PubMed ID: 28691891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of metallo-β-lactamase NDM-1- and OXA-23 carbapenemase-producing Acinetobacter baumannii in Libyan hospitals.
    Mathlouthi N; El Salabi AA; Ben Jomàa-Jemili M; Bakour S; Al-Bayssari C; Zorgani AA; Kraiema A; Elahmer O; Okdah L; Rolain JM; Chouchani C
    Int J Antimicrob Agents; 2016 Jul; 48(1):46-50. PubMed ID: 27216382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-occurrence of blaNDM-1 with blaOXA-23 or blaOXA-58 in clinical multidrug-resistant Acinetobacter baumannii isolates in Algeria.
    Ramoul A; Loucif L; Bakour S; Amiri S; Dekhil M; Rolain JM
    J Glob Antimicrob Resist; 2016 Sep; 6():136-141. PubMed ID: 27530856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii ST2 Clinical Isolate in Algeria: First Case Report.
    Bakour S; Olaitan AO; Ammari H; Touati A; Saoudi S; Saoudi K; Rolain JM
    Microb Drug Resist; 2015 Jun; 21(3):279-85. PubMed ID: 25588125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic characterisation of carbapenem-resistant Gram-negative bacteria isolated from the University Hospital Mohamed Boudiaf in Ouargla, southern Algeria.
    Yagoubat M; Ould El-Hadj-Khelil A; Malki A; Bakour S; Touati A; Rolain JM
    J Glob Antimicrob Resist; 2017 Mar; 8():55-59. PubMed ID: 28007519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology of environmental and clinical carbapenemase-producing Gram-negative bacilli from hospitals in Guelma, Algeria: Multiple genetic lineages and first report of OXA-48 in Enterobacter cloacae.
    Bouguenoun W; Bakour S; Bentorki AA; Al Bayssari C; Merad T; Rolain JM
    J Glob Antimicrob Resist; 2016 Dec; 7():135-140. PubMed ID: 27794265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular detection of OXA carbapenemase genes in multidrug-resistant Acinetobacter baumannii isolates from Iraq and Georgia.
    Kusradze Ia; Diene SM; Goderdzishvili M; Rolain JM
    Int J Antimicrob Agents; 2011 Aug; 38(2):164-8. PubMed ID: 21616644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon.
    Al Atrouni A; Hamze M; Jisr T; Lemarié C; Eveillard M; Joly-Guillou ML; Kempf M
    Int J Infect Dis; 2016 Nov; 52():29-36. PubMed ID: 27663910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Acinetobacter baumannii clinical isolates carrying bla(OXA-23) carbapenemase and 16S rRNA methylase armA genes in Yemen.
    Bakour S; Alsharapy SA; Touati A; Rolain JM
    Microb Drug Resist; 2014 Dec; 20(6):604-9. PubMed ID: 24901296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acinetobacter baumannii clonal lineages I and II harboring different carbapenem-hydrolyzing-β-lactamase genes are widespread among hospitalized burn patients in Tehran.
    Mahdian S; Sadeghifard N; Pakzad I; Ghanbari F; Soroush S; Azimi L; Rastegar-Lari A; Giannouli M; Taherikalani M
    J Infect Public Health; 2015; 8(6):533-42. PubMed ID: 26111484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct detection of carbapenemase-associated proteins of Acinetobacter baumannii using nanodiamonds coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Chang KC; Chung CY; Yeh CH; Hsu KH; Chin YC; Huang SS; Liu BR; Chen HA; Hu A; Soo PC; Peng WP
    J Microbiol Methods; 2018 Apr; 147():36-42. PubMed ID: 29499232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal relatedness and biofilm formation of OXA-23-producing carbapenem resistant Acinetobacter baumannii isolates from hospital environment.
    Aliramezani A; Douraghi M; Hajihasani A; Mohammadzadeh M; Rahbar M
    Microb Pathog; 2016 Oct; 99():204-208. PubMed ID: 27569533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of carbapenem non-susceptible multidrug resistant Acinetobacter baumannii strains of clonal complexes 103(B) and 92(B) harboring OXA-type carbapenemases and metallo-β-lactamases in Southern India.
    Saranathan R; Vasanth V; Vasanth T; Shabareesh PR; Shashikala P; Devi CS; Kalaivani R; Asir J; Sudhakar P; Prashanth K
    Microbiol Immunol; 2015 May; 59(5):277-84. PubMed ID: 25726848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan.
    Lee MH; Chen TL; Lee YT; Huang L; Kuo SC; Yu KW; Hsueh PR; Dou HY; Su IJ; Fung CP
    J Microbiol Immunol Infect; 2013 Dec; 46(6):419-24. PubMed ID: 23010539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a teaching hospital in China.
    Hu Q; Hu Z; Li J; Tian B; Xu H; Li J
    J Basic Microbiol; 2011 Oct; 51(5):467-72. PubMed ID: 21656808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii isolates from Tunisia.
    Jaidane N; Naas T; Oueslati S; Bernabeu S; Boujaafar N; Bouallegue O; Bonnin RA
    Int J Antimicrob Agents; 2018 Dec; 52(6):916-921. PubMed ID: 29857033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital.
    Elabd FM; Al-Ayed MS; Asaad AM; Alsareii SA; Qureshi MA; Musa HA
    J Infect Public Health; 2015; 8(3):242-7. PubMed ID: 25466594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of Acinetobacter baumannii in different hospitals in Tripoli, Lebanon using bla(OXA-51-like) sequence based typing.
    Rafei R; Pailhoriès H; Hamze M; Eveillard M; Mallat H; Dabboussi F; Joly-Guillou ML; Kempf M
    BMC Microbiol; 2015 May; 15():103. PubMed ID: 25976451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.